acut
respiratori
distress
syndrom
ard
clinic
biolog
heterogen
syndrom
sever
lung
inflamm
disord
present
rapidli
progress
hypoxemia
ard
princip
associ
direct
injuri
lung
infecti
pneumonia
indirect
injuri
lung
result
system
inflamm
sepsi
trauma
pneumonia
remain
predomin
caus
death
children
year
common
trigger
ard
pediatr
ard
one
lethal
diseas
pediatr
intens
care
unit
picu
associ
high
rate
histor
pediatr
ard
defin
use
adult
ard
criteria
base
consensu
berlin
definit
pediatr
acut
lung
injuri
consensu
confer
publish
definit
ard
accord
berlin
definit
sever
ard
defin
hypoxemia
mm
hg
arteri
partial
pressur
oxygen
mm
hg
fraction
inspir
oxygen
ratio
pf
ratio
posit
pressur
peep
cm
previous
report
children
avian
influenza
viru
infect
develop
sever
ard
show
directli
infect
injur
alveolar
epitheli
cell
correl
express
level
lung
tissu
patholog
molecular
biolog
examin
biopsi
infect
lung
emerg
virus
avian
influenza
viru
sever
acut
respiratori
syndrom
corona
viru
middl
east
respiratori
syndrom
corona
also
caus
primari
viral
pneumonia
high
incid
ard
sever
retrospect
studi
case
report
examin
pathogen
involv
develop
ard
prospect
observ
studi
investig
viral
bacteri
etiolog
ard
pulmonari
dysregul
inflamm
caus
excess
innat
immun
respons
host
immun
system
report
one
pathogenesi
complex
network
inflammatori
mediat
initi
amplifi
inflammatori
respons
ard
sever
studi
shown
alter
innat
respons
hypercytokinemia
patient
ard
develop
sever
inflammatori
mediat
report
biomark
ard
potenti
predictor
poor
howev
studi
examin
inflammatori
respons
specif
sever
ard
pulmonari
origin
children
respiratori
viru
infect
primari
aim
studi
examin
pathogen
contribut
sever
ard
pulmonari
origin
children
secondari
aim
examin
profil
inflammatori
mediat
investig
prognost
factor
fatal
outcom
sever
ard
pulmonari
origin
children
use
multivari
analysi
studi
carri
decemb
may
picu
nation
children
hospit
hanoi
vietnam
children
fulfil
follow
inclus
criteria
enrol
admiss
picu
infecti
pneumonia
age
month
year
complic
sever
ard
pf
ratio
mm
hg
peep
cm
base
berlin
definit
perform
least
one
ga
analysi
within
h
picu
admiss
presenc
new
bilater
infiltr
chest
radiographi
exclud
children
dysplasia
chronic
lung
diseas
right
left
shunt
congenit
heart
diseas
notabl
measl
outbreak
occur
among
vietnames
children
first
half
year
studi
blood
tracheal
lavag
fluid
tlf
sampl
collect
day
picu
admiss
one
two
millilit
tlf
recov
ad
ml
steril
salin
patient
intub
tube
blood
andor
tlf
cultur
perform
detect
bacteria
fungi
detect
differenti
pathogen
microbi
dna
blood
sampl
lightcycl
septifast
test
roch
diagnost
gmbh
manheim
germani
total
nucleic
acid
tlf
sampl
extract
use
roch
magna
pure
lc
instrument
magna
pure
lc
total
nucleic
acid
isol
kit
roch
diagnost
extract
test
use
respiratori
viru
panel
rvp
fast
assay
luminex
molecular
diagnost
inc
toronto
canada
instrument
luminex
molecular
diagnost
inc
rvp
fast
assay
simultan
detect
identifi
respiratori
viral
genom
adenoviru
speci
b
measl
viru
mev
cytomegaloviru
cmv
human
herp
detect
develop
convent
revers
transcriptas
rt
assay
pcr
describ
sampl
posit
respiratori
syncyti
viru
rsv
enteroviru
ev
human
rhinoviru
hrv
rvp
fast
assay
subtyp
rsv
evhrv
ev
determin
combin
result
rvp
fast
assay
type
respiratori
viru
genom
investig
tabl
ehrlichia
rickettsia
dna
forward
revers
probe
gcctggggactacggtcgcaaga
mycoplasma
pneumocysti
jirovecii
detect
pcr
use
quantitect
probe
pcr
master
mix
qiagen
hilden
germani
specif
primer
probe
set
level
inflammatori
cytokineschemokin
serum
measur
day
picu
admiss
use
human
cytokin
magnet
panel
kit
invitrogen
carlsbad
ca
instrument
luminex
molecular
diagnost
inc
assay
determin
concentr
follow
cytokin
human
granulocyt
macrophag
factor
interferon
ifn
interleukin
il
tumor
necrosi
factor
tnf
serum
level
high
mobil
group
box
measur
use
elisa
kit
ii
corp
tokyo
japan
late
inflammatori
mediat
acut
lung
sampl
run
duplic
averag
concentr
use
statist
analysi
u
test
use
determin
statist
signific
differ
clinic
data
cytokinechemokin
level
group
fisher
exact
test
use
bivari
analysi
categor
data
associ
cytokinechemokin
level
clinic
data
test
linear
regress
analysi
assess
good
fit
linear
regress
model
measur
use
use
logist
regress
analysi
analyz
relationship
independ
outcom
predictor
outcom
assess
good
fit
logist
regress
model
test
use
characterist
roc
curv
area
curv
auc
calcul
predict
analysi
analys
perform
use
spss
softwar
spss
inc
chicago
il
p
valu
consid
indic
statist
signific
biomed
research
ethic
committe
nation
children
hospit
research
institut
child
health
approv
number
ethic
committe
nation
institut
infecti
diseas
approv
number
review
approv
protocol
studi
written
inform
consent
obtain
parent
legal
guardian
patient
total
children
fulfil
criteria
first
enrol
detect
pathogen
contribut
sever
ard
pulmonari
origin
tlf
sampl
children
one
respiratori
viru
genom
detect
serum
sampl
cytokin
chemokin
assay
avail
patient
thu
total
children
sever
ard
pulmonari
origin
respiratori
viru
infect
enrol
studi
demograph
clinic
data
summar
tabl
patient
boy
girl
rang
age
month
year
median
month
children
less
year
old
twelv
children
medic
histori
pneumonia
n
febril
convuls
n
idiopath
thrombocytopen
purpura
n
hemosiderosi
n
two
children
posit
human
immunodefici
viru
median
durat
onset
ill
picu
admiss
day
patient
admit
picu
within
day
onset
ill
median
pf
ratio
mm
hg
children
show
pf
ratio
mm
hg
peep
cm
day
picu
admiss
children
intub
support
mechan
ventil
pediatr
risk
mortal
prism
iii
score
assess
use
paramet
obtain
first
h
stay
prism
iii
score
median
glucocorticoid
intravascular
immunoglobulin
administ
children
respect
adjunct
treatment
depend
physician
decis
fourteen
type
viral
genom
detect
tlf
sampl
children
show
multipl
viru
infect
detail
virus
detect
present
tabl
patient
posit
either
mev
cmv
addit
patient
bacteri
fungal
infect
addit
viral
infect
tabl
screen
cmv
infect
possibl
caus
sever
ard
pulmonari
origin
observ
mani
immunocompet
infant
pneumonia
percent
children
virus
cmv
infect
consid
opportunist
infect
follow
infect
anoth
viru
commonli
detect
bacteria
fungi
klebsiella
pneumonia
follow
acinetobact
baumannii
candida
albican
gener
consid
opportunist
nosocomi
infect
tabl
streptococcu
pneumonia
repres
pathogen
pneumonia
detect
two
children
measl
taken
togeth
case
sever
ard
pulmonari
origin
present
studi
develop
viral
pneumonia
rather
primari
bacteri
pneumonia
patient
bacteremia
fungemia
tabl
children
die
picu
nearli
half
die
within
first
day
picu
admiss
studi
survivor
discharg
picu
aliv
shown
tabl
signific
differ
gender
age
peep
valu
primari
set
clinic
featur
prism
iii
score
treatment
multipl
viru
infect
infect
mev
infect
cmv
infect
bacteria
fungal
infect
bacteremia
fungemia
survivor
differ
observ
patient
medic
histori
underli
condit
peep
valu
maximum
set
day
ill
picu
admiss
later
day
compar
survivor
day
show
margin
signific
differ
p
suggest
tendenc
admiss
delay
median
durat
picu
stay
day
shorter
survivor
day
p
serum
level
detect
limit
case
thu
differ
level
investig
cytokin
associ
initi
effect
inflammatori
process
infect
cytokin
control
downregul
inflammatori
respons
accord
anoth
classif
type
cytokin
produc
helper
type
lymphocyt
predominantli
promot
immun
type
cytokin
produc
helper
type
lymphocyt
predominantli
support
humor
immun
antibodi
cytokineschemokin
produc
simultan
counteract
effect
notabl
level
ratio
ratio
significantli
higher
survivor
tabl
level
associ
fatal
outcom
influenc
mev
bacterialfung
infect
fig
ratio
suggest
rel
balanc
type
type
ratio
higher
indic
greater
predomin
day
picu
admiss
ratio
ratio
suggest
rel
balanc
cytokin
cytokin
show
differ
survivor
higher
level
observ
children
lower
level
observ
children
fig
addit
ratio
ratio
significantli
increas
children
compar
uninfect
children
fig
higher
ratio
reflect
lower
level
patient
fig
b
higher
ratio
reflect
higher
data
shown
lower
level
patient
fig
patient
bacterialfung
exhibit
markedli
higher
level
compar
uninfect
patient
differ
level
ratio
patient
without
bacterialfung
infect
fig
focus
level
day
picu
admiss
analyz
factor
associ
increas
level
children
sever
ard
pulmonari
origin
respiratori
viru
infect
linear
regress
analysi
perform
investig
associ
level
patient
characterist
includ
age
gender
durat
onset
ill
picu
admiss
fatal
outcom
infect
bacterialfung
infect
tabl
variabl
modifi
probabl
patient
high
serum
concentr
fatal
outcom
r
found
fatal
outcom
associ
high
serum
level
picu
admiss
addit
logist
regress
analysi
independ
predictor
fatal
outcom
perform
good
fit
model
verifi
test
p
durat
onset
ill
picu
admiss
serum
level
day
picu
admiss
associ
fatal
outcom
tabl
also
calcul
auc
roc
curv
serum
level
result
ci
indic
predict
fatal
outcom
moder
accuraci
taken
togeth
serum
level
day
picu
admiss
potenti
predictor
fatal
outcom
acut
onset
ard
one
lethal
clinic
cours
infecti
respiratori
diseas
present
studi
focus
sever
ard
pulmonari
origin
children
respiratori
viru
infect
inflammatori
respons
sever
ard
develop
viral
pneumonia
thought
relat
primari
respiratori
infect
system
inflammatori
respons
studi
prospect
examin
infecti
pathogen
host
inflammatori
respons
measur
serum
level
cytokin
chemokin
day
picu
admiss
etiolog
sever
ard
pulmonari
origin
children
found
least
one
viral
genom
detect
tlf
nearli
children
result
consist
sever
report
reveal
respiratori
virus
major
caus
pathogen
children
hospit
acut
respiratori
high
frequenc
multipl
viru
infect
bacterialfung
observ
enrol
children
recent
becom
possibl
detect
multipl
viru
genom
simultan
high
sensit
use
molecular
detect
techniqu
therefor
detect
viru
genom
previous
possibl
may
one
reason
high
frequenc
viral
infect
multipl
infect
anoth
possibl
reason
measl
outbreak
occur
first
half
year
studi
period
decemb
may
immunosuppress
may
result
increas
suscept
viru
infect
increas
frequenc
multipl
viru
among
enrol
children
children
admit
measl
outbreak
children
detect
frequenc
mev
outbreak
significantli
higher
outbreak
june
may
howev
frequenc
multipl
viru
infect
children
outbreak
children
outbreak
differ
signific
fisher
exact
test
p
therefor
frequenc
multipl
viru
infect
studi
significantli
associ
measl
outbreak
frequent
detect
viru
genom
tlf
previou
studi
report
children
die
pneumonia
picu
measl
outbreak
complic
type
adv
type
caus
seriou
lower
respiratori
diseas
develop
sever
ard
particularli
hospit
children
children
immunosuppress
mev
infect
among
children
children
admit
outbreak
children
admit
outbreak
differ
detect
frequenc
measl
outbreak
fisher
exact
test
p
associ
type
caus
pathogen
rather
inflammatori
respons
induc
host
immun
evalu
differ
serum
level
inflammatori
mediat
survivor
day
picu
admiss
examin
associ
type
infect
pathogen
found
serum
level
associ
fatal
outcom
fig
tabl
consid
limit
sampl
size
result
logist
regress
analysi
p
suggest
predictor
fatal
outcom
auc
fatal
outcom
predict
level
confid
interv
show
moder
accur
predict
cytokin
cytokin
play
critic
role
immun
respons
viral
infect
directli
inhibit
viral
replic
sever
studi
inflammatori
respons
infecti
viral
diseas
serum
plasma
level
found
elev
hospit
children
children
sever
dengu
rare
report
prognost
mediat
ard
report
one
independ
outcom
predictor
shown
studi
particularli
children
sever
ard
pulmonari
origin
respiratori
viru
infect
found
serum
level
possibl
prognost
factor
fatal
outcom
serum
level
report
relat
poor
prognosi
ard
studi
serum
level
higher
children
bacteri
fungal
children
viral
infect
although
level
associ
fatal
outcom
serum
level
associ
fatal
outcom
also
mev
infect
adv
infect
fig
therefor
appear
suitabl
independ
prognost
factor
fatal
outcom
ratio
associ
fatal
outcom
higher
ratio
day
picu
admiss
thought
reflect
inflammatori
present
studi
limit
first
sampl
size
small
second
result
particularli
type
detect
viru
genom
may
affect
concurr
measl
outbreak
third
includ
data
healthi
vietnames
children
age
control
thu
could
compar
serum
level
inflammatori
mediat
healthi
children
fourth
viru
necessarili
caus
pathogen
diseas
persist
adv
cmv
infect
establish
primari
infect
may
detect
healthi
fifth
genom
rna
virus
degrad
time
sampl
collect
primer
probe
bind
sequenc
mutat
genom
could
detect
sixth
pathogen
may
present
detect
summari
first
report
determin
profil
pathogen
involv
sever
ard
pulmonari
origin
children
respiratori
viru
infect
found
upregul
detect
day
picu
admiss
one
possibl
prognost
factor
affect
fatal
outcom
rather
type
pathogen
suggest
modul
inflammatori
respons
regardless
pathogen
type
critic
clinic
manag
patient
